THE RISK OF SUBSEQUENT OSTEOPOROTIC FRACTURES IS DECREASED IN PATIENTS EXPERIENCING FRACTURE WHILE ON DENOSUMAB: RESULTS FROM THE FREEDOM AND FREEDOM EXTENSION STUDIES